# Kos Biotechnology Partners Announces Investment in Fathom Therapeutics to Advance Novel, AI-Driven Drug Discovery Platform

- Source: PR Newswire M&A
- Published: 2026-11-06T11:00:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/kos-biotechnology-partners-announces-investment-in-fathom-therapeutics-to-advance-novel-ai-driven-drug-discovery-platform-302931959.html
- Canonical: https://groundlevelnews.com/story/kos-biotechnology-partners-announces-investment-in-fathom-therapeutics-36a8a7/

Kos joins Sutter Hill Ventures and other leading investors in backing Fathom Therapeutics's pioneering physics- and AI-powered drug discovery platform NEW YORK and ATHENS, Greece, Nov. 6, 2026 /PRNewswire/ -- Kos Biotechnology Partners ("Kos"), a global life sciences investment firm...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._